ALPINE IMMUNE SCIENCES, INC. Human Resources Contracts & Agreements
46 Contracts & Agreements
- Bonus & Incentive Agreements (8 contracts)
- Change of Control Agreements (2)
- Compensation Agreements (5)
- Employment Agreements (27)
- Separation Agreements (4)
- Non-Employee Director Compensation Guidelines (Filed With SEC on March 20, 2024)
- Alpine Immune Sciences, Inc. Change of Control and Severance Policy, as amended and restated effective January 4, 2024 (Filed With SEC on January 5, 2024)
- Employment Agreement, dated as of September 20, 2023, by and between (Filed With SEC on November 14, 2023)
- Employment Agreement, dated as of January 1, 2020, by and between the Registrant and Remy Durand M.D., Ph.D (Filed With SEC on May 11, 2023)
- Executive Employment Agreement, dated as of May 27, 2022, by and between Alpine Immune Sciences, Inc. and Andrew Sandler (Filed With SEC on August 11, 2022)
- Separation Agreement, dated as of October 8, 2021, by and between the Registrant and Zelanna Goldberg (Filed With SEC on March 17, 2022)
- Executive Employment Agreement, dated June 1, 2021, by and between the Company and Zelanna Goldberg (Filed With SEC on August 10, 2021)
- Non-Employee Director Compensation Guidelines (Filed With SEC on March 18, 2021)
- 2018 Equity Incentive Plan, as amended (Filed With SEC on June 17, 2020)
- Form of Restricted Stock Unit Agreement under the 2018 Equity Incentive Plan (Filed With SEC on January 27, 2020)
- Separation Agreement, dated April 24, 2019, by and between the Company and Mark Litton (Filed With SEC on August 13, 2019)
- Alpine Immune Sciences, Inc. Non-Employee Director Compensation Guidelines (Filed With SEC on April 1, 2019)
- Alpine Immune Sciences, Inc. Executive Incentive Compensation Plan (Filed With SEC on April 1, 2019)
- Executive Employment Agreement, dated August 6, by and between the Company and Mark Litton (Filed With SEC on August 6, 2018)
- Form of Stock Option Agreement under the 2018 Equity Incentive Plan (Filed With SEC on June 14, 2018)
- Alpine Immune Sciences, Inc. 2018 Equity Incentive Plan (Filed With SEC on June 14, 2018)
- Non-Employee Director Compensation Guidelines (Filed With SEC on May 14, 2018)
- Employment Agreement, dated as of January 1, 2018 , by and between the Registrant and Stanford Peng, M.D., Ph.D (Filed With SEC on March 28, 2018)
- Employment Agreement, dated as of August 14, 2016, by and between the Registrant and Stanford Peng, M.D., Ph.D (Filed With SEC on March 28, 2018)
- Employment Agreement, dated as of January 1, 2018, by and between the Registrant and Paul Rickey (Filed With SEC on March 28, 2018)
- Employment Agreement, dated as of April 1, 2017, by and between the Registrant and Paul Rickey (Filed With SEC on March 28, 2018)
- Employment Agreement, dated as of January 1, 2018, by and between the Registrant and Mitchell H. Gold, M.D (Filed With SEC on March 28, 2018)
- Employment Agreement, dated as of March 14, 2017, by and between the Registrant and Mitchell H. Gold, M.D (Filed With SEC on March 28, 2018)
- Form of Executive Employment Agreement (Filed With SEC on December 11, 2017)
- Change of Control and Severance Policy (Filed With SEC on December 11, 2017)
- AMENDMENT to the EMPLOYMENT AGREEMENT between Nivalis Therapeutics, Inc. and Jon Congleton (“Employee”) (Filed With SEC on February 13, 2017)
- CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE (Filed With SEC on February 13, 2017)
- AMENDMENT to the EMPLOYMENT AGREEMENT between Nivalis Therapeutics, Inc. and David M. Rodman, M.D. (“Employee”) (Filed With SEC on February 13, 2017)
- AMENDMENT to the EMPLOYMENT AGREEMENT between Nivalis Therapeutics, Inc. and R. Michael Carruthers (“Employee”) (Filed With SEC on February 13, 2017)
- AMENDMENT to the EMPLOYMENT AGREEMENT between Nivalis Therapeutics, Inc. and Janice M. Troha (“Employee”) (Filed With SEC on February 13, 2017)
- CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE (Filed With SEC on February 13, 2017)
- EMPLOYMENT AGREEMENT (Filed With SEC on May 3, 2016)
- Nivalis Therapeutics, Inc. Non-Employee Director Compensation Guidelines Effective July 16, 2015 (Filed With SEC on August 4, 2015)
- AMENDMENT to the EMPLOYMENT AGREEMENT Effective November 1, 2012 between Nivalis Therapeutics, Inc. (formerly known as N30 Pharmaceuticals, Inc.) and Sherif E. Gabriel (Employee) (Filed With SEC on May 13, 2015)
- AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on May 13, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on May 13, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on May 13, 2015)
- AMENDMENT to the EMPLOYMENT AGREEMENT Effective November 1, 2012 between Nivalis Therapeutics, Inc. (formerly known as N30 Pharmaceuticals, Inc.) and Janice M. Troha (Employee) (Filed With SEC on May 13, 2015)
- AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on May 13, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on May 13, 2015)
